Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Terminated 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma 7Leiomyosarcoma 3Sarcoma, Synovial 2Sarcoma, Alveolar Soft Part 2Ovarian Neoplasms 2Neurofibrosarcoma 2Malignant mesenchymal tumor 2Liposarcoma 2Histiocytoma, Malignant Fibrous 2Hemangiosarcoma 2Hemangiopericytoma, Malignant 2Fibrosarcoma 2Unspecified Childhood Solid Tumor, Protocol Specific 1Unspecified Adult Solid Tumor, Protocol Specific 1Solitary Fibrous Tumors 1Soft Tissue Neoplasms 1Sarcoma, Ewing 1Sarcoma, Endometrial Stromal 1Rhabdomyosarcoma 1Recurrent High Grade Meningioma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasm Metastasis 1Ichthyosis, X-Linked 1Gastrointestinal Stromal Tumors 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Desmoplastic Small Round Cell Tumor 1Chondrosarcoma, Mesenchymal 1Chondrosarcoma, Extraskeletal Myxoid 1Central Nervous System Neoplasms 1

Interventions

Doxorubicin 2indolepropanol phosphate 1X-Rays 1Watchful Waiting 1Trabectedin 1Surgical Procedures, Operative 1Radiotherapy, Conformal 1Radiotherapy 1Observation 1Ifosfamide 1Drug Therapy 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Chondrosarcoma, Extraskeletal Myxoid × Trabectedin × Clear all
NCT01189253 2014-08-08

Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2/3 Terminated
133 enrolled
Sarcoma

Malignant mesenchymal tumor, Hemangiopericytoma, Malignant, Chondrosarcoma, Extraskeletal Myxoid, Fibrosarcoma, Hemangiosarcoma, Leiomyosarcoma, Sarcoma, Sarcoma, Synovial, Sarcoma, Alveolar Soft Part, Neurofibrosarcoma, Histiocytoma, Malignant Fibrous, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡